Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 841-846, June 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bresnick, E.
Right arrow Articles by Karjala, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bresnick, E.
Right arrow Articles by Karjala, R. J.

End-Product Inhibition of Thymidine Kinase Activity in Normal and Leukemic Human Leukocytes*

Edward Bresnick and R. J. Karjala

( Department of Pharmacology, Baylor University College of Medicine, Houston, Texas)

Thymidine kinase activity in sonicated soluble preparations obtained from normal and leukemic human leukocytes (both chronic myelogenous and chronic lymphocytic leukemia) was inhibited by the 5'-mono-, di-, and triphosphates of 2'-deoxythymidine (TMP, TDP, and TTP, respectively), by 2'-deoxycytidine-5'-monophosphate (d-CMP), and by 2'-deoxycytidine-5'-triphosphate (d-CTP). The inhibitions by TTP and d-CTP were of the competitive type (with thymidine). The ‘apparent’ Km for thymidine and the Ki for TTP and d-CTP were 3.6 x 10-5, 1.5 x 10-6, and 7.6 x 10-6M, respectively. Comparable results were obtained with preparations obtained from normal or leukemic leukocytes. Thymidine kinase in these leukocyte preparations was gradually inactivated at 50° C. The degree of end-product inhibition by d-CTP or TTP was not affected by this heat treatment of the leukocyte preparations.

* This work was supported in part by an institutional grant from the American Cancer Society, ACS In 27E Project 8, and by a grant from the National Cancer Institute (CA 06571), United States Public Health Service.

Received 12/28/63.


This article has been cited by other articles:


Home page
ScienceHome page
R. R. Klevecz
Temporal coordination of DNA replication with enzyme synthesis in diploid and heteroploid cells.
Science, December 19, 1969; 166(3912): 1536 - 1538.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.